<DOC>
	<DOC>NCT01086501</DOC>
	<brief_summary>The aim of the observational study is to investigate the safety of oxcarbazepine extended release (ER) during long-term therapy in epileptic patients. In addition, quality of life parameters should be documented if assessed.</brief_summary>
	<brief_title>ESOXC-ER Efficacy and Safety of an Extended Release (ER) Formulation of Oxcarbazepine (Apydan Extent) in Epileptic Patients</brief_title>
	<detailed_description />
	<mesh_term>Oxcarbazepine</mesh_term>
	<criteria>patients with focal epileptic seizures with or without secondary generalised tonicclonic seizures mono or combination therapy male and female from the age of 6 hypersensitivity to oxcarbazepine MR or one of its excipients</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>open, non-interventional</keyword>
</DOC>